Predict your next investment

Private Equity
szmaliang.com

See what CB Insights has to offer

Investments

1

Funds

1

About Maliang Capital

Maliang Capital (马良资本) is a private equity investment management firm focusing on medical, new material and new energy.

Maliang Capital Headquarter Location

1402, Modern International Tower, Jintian Road No.3038 Futian District

Shenzhen, Guangdong,

China

0755-2399 2794

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Maliang Capital Investments

1 Investments

Maliang Capital has made 1 investments. Their latest investment was in InnerMedical as part of their Series A on January 1, 2019.

CBI Logo

Maliang Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/2/2019

Series A

InnerMedical

Yes

3

Date

1/2/2019

Round

Series A

Company

InnerMedical

Amount

New?

Yes

Co-Investors

Sources

3

Maliang Capital Fund History

1 Fund History

Maliang Capital has 1 fund, including Shenzhen Maliang Jiaolong III Investment Center.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Shenzhen Maliang Jiaolong III Investment Center

Diversified Private Equity

Open

1

Closing Date

Fund

Shenzhen Maliang Jiaolong III Investment Center

Fund Type

Diversified Private Equity

Status

Open

Amount

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.